Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
Home > Patient Care > Clinical Trials: Open Enrollment   
Clinical Trials: Open Enrollment
The following is a listing of all trials currently enrolling brain tumor patients at UCLA.
What clinical trials are available at UCLA Neuro-Oncology?
Choosing to participate in a clinical trial is an important, personal decision. It is often helpful to talk to a physician, family members, or friends about deciding to join a trial. After identifying some trial options, the next step is to contact the study research staff and ask questions about specific trials.

For more information about any of the UCLA Neuro-Oncology Program’s clinical trials listed, please contact Emese Filka, Clinical Trials Coordinator, at (310) 794-3521

Study AgentIRB IDTrial:Details
MEDI473614-001460[Ludwig LUD2013-006]:
18-FDG16-000600Dr. Ellingson 18-FDG-PET (2016):
5-FC (Flucytosine)10-001147[Tg 511-09-01]:
ABT 41416-000649Abbvie M13-813 (RTOG 3508) :
ACP-19615-001667[Acerta ACE-ST-209]:
aCTL and IL-211-000790[aCTL Immunotherapy (Dr Liau)]:
CDX-110, Temozolomide11-002220[Celldex CDX110-05] :
Lapatinib (GW572016), TMZ, RT12-000493[Lapatinib_Nghiemphu]:
Nivo16-000365BMS CA209548:
Nivo16-000207BMS CA209-498:
Nivolumab, the combination of Nivolumab and ipilimumab14-000075[BMS CA209143]:
Toca 51115-001608[Tg 511-15-01]:
VB-11115-001545 VBL VB-111-215 :

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2018 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2018 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:1/23/2018 3:15:44 PM PST]